Viewing StudyNCT00065325



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00065325
Status: COMPLETED
Last Update Posted: 2015-02-24
First Post: 2003-07-21

Brief Title: The Evaluation of the Efficacy and Tolerability of FASLODEX Fulvestrant and AROMASIN Exemestane in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Metastatic Breast Cancer
Locally Advanced Breast Cancer
Keywords:
Name View
Cancer of the Breast View
Locally advanced breast cancer View
metastatic breast cancer View
Breast Cancer View
Cancer of Breast View